Medicenna Therapeutics Corporation (QX) (MDNAF) 銘柄情報

Big conference next week. Paris.

Oui oui!

Bollies on daily are tightening up kids. Big conference coming up in sept

Research-Capital analyst- $MDNAF buy rating & $4.5 TP

MDNA11 continue to demonstrate compelling efficacy:
2 patients #melanoma & #pancreatic treated with MDNA11 continue to demonstrate a complete response

Notably, both patients were previously treated with checkpoint inhibitors

And more awesome results. 20x bagger here soon? Pc needs a new top line therapy, guess who?

MDNAF is a presenter at ASCO. Huge news!

Great presentation at ASCO

It is what they all say about stonks trading on Cromwell Coulson’s stonk market

Relishing soon. This will be 10x current value this year

Delisted from Nasdaq
Gee, it sure is great to watch the price of a stock I bought at $400 a share advance to a 52=week high

Getting legs here. Train leaving.

Cash runway extended through multiple data readouts and into Q1 of calendar 2025

MDNA11 is generally well tolerated and continues to demonstrate encouraging single-agent activity from Phase 1 portion of the ABILITY-1 Study including 100% and 70% reduction of target lesions in pancreatic and melanoma cancer patients, respectively

https://ir.medicenna.com/news-releases/news-release-details/medicenna-therapeutics-reports-second-quarter-fiscal-2024

MDNA changed to MDNAF. Delisted from the Nasdaq to the OTC.

https://otce.finra.org/otce/dailyList?viewType=Additions

MDNA new 52 week low

MDNA new 52 week low

MDNA NEW 52 week low

Medicenna Therapeutics $MDNA highlighted in Midas Letter/BioPub interview: Top Stocks to Buy Now? 3 Biotech Stocks for your Watchlist

Going much higher. Double digits in a few months

Nice after hours action, Just made 20,000. Yadda Yadda Yadda.

Nobody is here listening to me. THis one is going to be a beast tho

FDA meeting Tuesday. Seems like we'll know sometime in October the results

This is my largest holding -- ever. Lots of value to be unveiled here in the coming months.

MDNA moved from the OTC to the Nasdaq:

https://otce.finra.org/otce/dailyList?viewType=Deletions

Just stumbled onto this co.. was doing some research. Great interim results in their Phase2b! Encouraging grants in the past, and prestigious medical centers for their trials. I may nibble to create a starting position here.

I can't find any webinars or conf call recordings that the company has given, do you know if any exist?

Nice move yesterday ..

Small Phase 2b trial has huge chance to be successful because it was already successfull in prior studies so this stock like to be above $10 after phase 2 results in early Q1 . And that Management holding 15+ million shares of the 24.3 million shares outstanding makes me also optimistic .GL


MDNA55 is enrolling patients in a Phase 2b clinical trial for rGB at leading brain cancer centres in the US. MDNA55 has completed 3 clinical trials in 72 patients, including 66 adults with rGB, demonstrated compelling efficacy and obtained Fast-Track and Orphan Drug status from USFDA. Unlike most other cancer therapies, Medicenna's IL4-ECs have the potential to purge both the tumor and the immunosuppressive tumor microenvironment,


Medicenna Phase 2b trial using Brainlab technology
http://www.biotuesdays.com/briefs/2017/6/8/medicenna-phase-2b-trial-using-brainlab-technology

The current Phase 2b clinical trial plans to enroll 43 adult patients with rGB at leading brain cancer centers in the U.S.